Trial Condition(s):
Hypertension
Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension, who do not tolerate ACE inhibitoR treatment (SONAR)
Bayer Identifier:
14010
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Trial Purpose
Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension, who do not tolerate ACE inhibitoR treatment
Inclusion Criteria
- Patients over 18 years of age - Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg) - Patients, who do not tolerate ACE inhibitors (must be documented in the official ambulant documentation) Inclusion criteria for the control arm (treated by ACEi): - Patients over 18 years of age - Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg) - Patients, who tolerate ACEi treatment
Exclusion Criteria
- Cholestasis, severe hepatic insufficiency - Allergy to telmisartan - Gravidity or lactation Exclusion criteria for the arm of patient treated by ACEi: - Cholestasis, severe hepatic insufficiency - Allergy to ACEi - Gravidity or lactation
Trial Summary
Enrollment Goal
Trial Dates
Phase
Could I receive a placebo?
Products
Accepts Healthy Volunteers
Where to Participate
| Locations | |
|---|---|
Locations Investigative Site Many Location, Slovakia | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Many Locations, Romania | Contact Us: E-mail: [email protected] Phone: Not Available |
Trial Design
Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension, who do not tolerate ACE inhibitoR treatment
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1
Primary Outcome
- To evaluate efficacy and safety of telmisartan in patients with arterial hypertension, who do not tolerate ACEI treatmentTimeframe: 1 year
Additional Information
Copyright © Bayer
Powered by
